Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | CCR1 | P32246 | 1/20 | 0.30 |
| ▸ | CCR5 | P51681 | 1/20 | 0.30 |
| ▸ | CCR8 | P51685 | 1/20 | 0.30 |
| ▸ | METAP1 | P53582 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.30 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4894768 | 0.85 | CCR1 (0.48) | KDM4ELMNACYP1A2POLBCCR1 | |
| SCHEMBL1047005 | 0.83 | KDM4E (0.61) | KDM4ELMNACYP1A2POLBCCR1 | |
| SCHEMBL17701188 | 0.80 | SCN9A (0.31) | — | |
| SCHEMBL3145603 | 0.80 | KDM4A (0.38) | KDM4ECYP1A2METAP1HIF1A | |
| SCHEMBL69777 | 0.80 | KMT2A (0.41) | — | |
| SCHEMBL1315590 | 0.78 | MAPT (0.42) | KDM4ELMNACYP1A2 | |
| SCHEMBL18421817 | 0.77 | GRM5 (0.44) | KDM4ELMNACYP1A2 | |
| SCHEMBL2750109 | 0.77 | NR4A2 (0.32) | LMNACYP1A2 | |
| SCHEMBL2753969 | 0.77 | ALOX5AP (0.32) | — | |
| SCHEMBL2753948 | 0.77 | HTR7 (0.36) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110118411-A1 | POLYMERIC COMPOUND HAVING RESIDUE OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-05-19 | — | — | US | claimed |
| EP-2275469-A1 | POLYMERIC COMPOUND HAVING RESIDUE OF NITROGENATED HETEROCYCLIC COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2011-01-19 | — | — | EP | claimed |
| JP-4093332-A | — | — | None | — | — | JP | disclosed |
| US-20240251665-A1 | TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE-INJECTION LAYER AND ORGANIC ELECTROLUMINESCENT ELEMENT | TOSOH CORPORATION (JP) | 2024-07-25 | — | — | US | disclosed |
| CN-118355011-A | Organic molecules for optoelectronic devices | 三星显示有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118215668-A | Organic molecules for optoelectronic devices | 三星显示有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-118201937-A | Organic molecules for optoelectronic devices | 三星显示有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-117999266-A | Organic molecules for optoelectronic devices | 三星显示有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-117980311-A | Organic molecules for optoelectronic devices | 三星显示有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117916247-A | Organic molecules for optoelectronic devices | 三星显示有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-117897390-A | Organic molecules for optoelectronic devices | 三星显示有限公司 | 2024-04-16 | — | — | CN | disclosed |
| US-20080045493-A1 | Heterocyclic Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor | ABBVIE DEUTSCHLAND GMBH & CO KG (DE) | 2008-02-21 | — | — | US | disclosed |
| EP-1814849-A1 | HETEROCYCLIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR | Abbott GmbH & Co. KG (DE) | 2007-08-08 | — | — | EP | disclosed |
| WO-2006040182-A1 | HETEROCYCLIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR | ABBOTT GMBH & CO. KG (DE) | 2006-04-20 | — | — | WO | disclosed |
| US-6114498-A | Benzobisazole polymers containing 2,2'-bipyridine-5,5 '-diyl moieties | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2000-09-05 | — | — | US | disclosed |
| US-6114498-A | Benzobisazole polymers containing 2,2'-bipyridine-5,5 '-diyl moieties | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2000-09-05 | — | — | US | disclosed |
| US-6114498-A | Benzobisazole polymers containing 2,2'-bipyridine-5,5 '-diyl moieties | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2000-09-05 | — | — | US | disclosed |
| US-5424381-A | Alkyl-substituted poly(2,2'-bipyridine-5,5'-diyl) and use thereof | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 1995-06-13 | — | — | US | disclosed |
| JP-H0493332-A | ORIENTATION FILM | YAMAMOTO RYUICHI | 1992-03-26 | — | — | JP | disclosed |
| JP-H00493332-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080045493-A1 | Heterocyclic Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor | DRD3, MC3R, CHRNA3 | KDM4E 4368/4885LMNA 3510/4885CYP1A2 854/4885 |
| US-20240251665-A1 | TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE-INJECTION LAYER AND ORGANIC ELECTROLUMINESCENT ELEMENT | AXIN2, FZD7, SLC39A3 | KDM4E 3963/4885LMNA 2480/4885CYP1A2 279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.